Request appointments with WOC nurses during WOCNext 2019, especially during dedicated time 11:00 am to 12 Noon Monday and Tuesday, June 24 and 25 when only exhibitors/WOC nurses who have confirmed appointments.

Search for qualified WOC nurses, connect via email and invite/facilitate one-on-one conversations.

Molnlycke Health Care  

Norcross,  GA 
United States
  • Booth: 706

Welcome WOCNs to the Mölnlycke Delivers Möre Experience

Mölnlycke is a world-leading medical solutions company. We design and supply solutions to enhance performance at every point of care – from the hospital to the home. We specialize in wound management, pressure ulcer prevention and surgical solutions with respected brands including Safetac®, Mepitel®, Mepilex®, HiBi® and Biogel®.

Brands: Safetac®, Mepitel®, Mepilex®, HiBi® and Biogel®.


  • Mepilex® Border Flex and Exufiber® Ag+
    Advanced foam dressing and gelling fiber for wound management...

  • Mepilex Border Flex was designed to conform and stay on for longer wear time and reduced dressing changes.  By reducing dressing changes, Mepilex Border Flex may support undisturbed wound healing as well as a reduction in cost.1,2  Innovative Flex Technology allows it to move in every direction, reducing skin stress, increasing comfort3-5 and keeping it in place. The five-layer dressing absorbs, channels and traps moderate to heavy exudate and allows you to track progress. It also keeps exudate containing bacteria from the wound bed and minimizes re-entry, even under compression.6

    For wounds with depth or additional exudate management needs, Exufiber Ag+  can be used in combination with Mepilex Border Flex. 

    Exufiber Ag+ dressings with Hydrolock® Technology are unique, next generation gelling fiber dressings made of tightly packed fibers to minimize the free space for fluid or exudate to flow, keeping it locked in. This structure simultaneously increases the integrity of the entire dressing to stay intact, without the need for reinforcing threads to hold it together.  

    Exufiber Ag+ efficiently transfers exudate from the wound bed to the secondary dressing,7 while locking in exudate to minimize leakage and reduce the risk for maceration. 8–11, 18 It promotes autolytic debridement,8  locks in exudate and stays intact both during use and at removal. 8-12  The superior exudate lock-in capacity11 provides moist wound healing and supports a clean wound bed, aimed at reducing additional nursing time for wound cleansing. Through the combination of Hydrolock Technology and silver sulfate, Exufiber Ag+ removes wound debris that supports bacteria growth and biofilm reformation. 16,17  It provides antimicrobial effect up to seven days on a broad range of pathogens 13–17.


    1. Tyson, L. Poster Presentation, SAWC Spring 2019. 2. Nelson, D. Poster Presentation, WOCNext 2019. 3.  PD529747. Data on file. 4. PD 534569 Data on file.  PD534560. Data on file. 5. PD534571. Data on file. PD537072. Data on file. 7. Mölnlycke Health Care. Data on file. (2018). 8. Chadwick P et al. Journal of Wound Care 2016; 25(4): 290-300. 9. Smet, S et al. Poster Presentation at European Pressure Ulcer Advisory Panel Conference, 2015, Ghent, Belgium. 10. Davies P et al. E-poster presentation at Wounds UK Conference, 2017, Harrogate, United Kingdom. 11. SMTL. TM-404. Mölnlycke Health Care. Data on file. (2014). 12. Swerea. Test method T-1117 rev. 0. Mölnlycke Health Care. Data on file. (2014). 13. Mölnlycke Health Care. CE: Performance of Exufiber Ag+ in vitro; Antimicrobial effect, silver release kinetics and minimal effective concentration. (Data on file, 2016.) 14. Hamberg K et al. Poster presented at the Symposium on Advanced Wound Care Spring meeting/Wound Healing Society (WHS) Annual Meeting 2017, Apr 05 - 09, 2017, San Diego, CA, USA. 15. Hamberg K et al. Poster presented at the Symposium on Advanced Wound Care Spring meeting/Wound Healing Society (WHS) Annual Meeting 2017, Apr 05 - 09, 2017, San Diego, CA, USA. 16. Gil et al. Poster presented at the Symposium on Advanced Wound Care Spring meeting/Wound Healing Society (WHS) Annual Meeting 2017, Apr 05 - 09, 2017, San Diego, CA, USA. 17. Davis et al. Preclinical evaluation of a novel silver gelling fiber dressing on Pseudomonas aeruginosa in a porcine wound infection model. Wound Rep Reg 2019, 27: 360-365. 18. Mölnlycke Health Care. Data on file. (2014).

  • Mepilex® Border Sacrum and Heel
    Proprietary Deep Defense™ technology helps to prevent pressure injuries, but also protects existing pressure injuries from further deterioration....

  • Only Mepilex Border dressings have over 80 evidence pieces to support their effectiveness in preventing pressure ulcers.1   The cost effectiveness of Mepilex Border Sacrum is supported by several clinical studies, including real-world  health economic evidence showing a $77 reduction in per patient treatment costs in a cohort of 1.03m patients. 2 

    When used for management of wounds, Mepilex Border Sacrum effectively absorbs and retains exudate and maintains a moist wound environment for optimal healing. 3, 4  The Safetac® technology layer seals the wound edges, preventing exudate leakage onto the surrounding skin which minimizes the risk of maceration.3 The Safetac technology layer allows the dressing to be changed without damaging the wound or surrounding skin,3 or exposing the patient to additional pain.5 


    1.Mölnlycke Health Care report: GMCS/2017/102/v8. Dressings for pressure ulcer prevention: a review of the pre-clinical, clinical and economic evidence (April 2018). Data on file.
    2.Padula William V. Effectiveness and value of prophylactic 5-layer foam sacral dressings to prevent hospital-acquired pressure injuries in acute care hospitals an observational cohort study. J Wound Ostomy Continence Nurs. 2017;44(5):1-6.
    3.Wiberg AB, et al. Preventing maceration with a soft silicone dressing: in-vitro evaluations. Poster presented at the 3rd Congress of WUWHS, Toronto, Canada. 4-8 June 2008.
    4.Meaume S, et al. A study to compare a new self-adherent soft silicone dressing with a self-adherent polymer dressing in stage II pressure ulcers. Ostomy Wound Manage. 2003;49(9):44-51.
    5.White R. A multinational survey of the assessment of pain when removing dressings. Wounds UK. 4 (1). 2008.

 Additional Info

WOCN Society Corporate Member?
Gold Level WOCN Society Supporter?
Supporting MyWOCN E-Community Networking?
For Technical Support with this webpage, please contact support.